Estrella Immunopharma (ESLA) Institutional Ownership $0.92 +0.07 (+8.23%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Estrella Immunopharma (NASDAQ:ESLA)CurrentInstitutional OwnershipPercentage0.35%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$44.40KNumber ofInstitutional Sellers(last 12 months)0 Get ESLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Estrella Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Estrella Immunopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 ATW Spac Management LLC40,000$44K0.1%N/A0.114% (Data available from 1/1/2016 forward) ESLA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ESLA shares? During the previous two years, the following institutional investors and hedge funds held shares of Estrella Immunopharma shares: ATW Spac Management LLC ($44K).Learn more on ESLA's institutional investors. What percentage of Estrella Immunopharma stock is owned by institutional investors? 0.35% of Estrella Immunopharma stock is owned by institutional investors. Learn more on ESLA's institutional investor holdings. Which institutional investors have been buying Estrella Immunopharma stock? The following institutional investors have purchased Estrella Immunopharma stock in the last 24 months: ATW Spac Management LLC ($40K). How much institutional buying is happening at Estrella Immunopharma? Institutional investors have bought a total of 40,000 shares in the last 24 months. This purchase volume represents approximately $44.40K in transactions. Related Companies Repare Therapeutics Institutional Ownership Context Therapeutics Institutional Ownership Innate Pharma Institutional Ownership Protalix BioTherapeutics Institutional Ownership Seres Therapeutics Institutional Ownership Alto Neuroscience Institutional Ownership Avalo Therapeutics Institutional Ownership InflaRx Institutional Ownership Cabaletta Bio Institutional Ownership Vaxart Institutional Ownership This page (NASDAQ:ESLA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
